Norway's new principles for primary prevention of cardiovascular disease: age differentiated risk thresholds

被引：15

作者：

Norheim, Ole Frithjof ^{[1
]}

Gjelsvik, Bjorn ^{[2
]}

Klemsdal, Tor Ole ^{[3
]}

Madsen, Steinar ^{[4
]}

Meland, Eivind ^{[1
]}

Narvesen, Stein ^{[5
]}

Negard, Anne ^{[6
]}

Njolstad, Inger ^{[7
]}

Tonstad, Serena ^{[3
]}

Ulvin, Froydis ^{[5
]}

Wisloff, Torbjorn ^{[8
]}

机构：

[1] Univ Bergen, Dept Publ Hlth & Primary Hlth Care, N-5018 Bergen, Norway

[2] Univ Oslo, Dept Primary Care & Publ Hlth, Oslo, Norway

[3] Oslo Univ Hosp, Dept Prevent Med, Oslo, Norway

[4] Norwegian Med Agcy, Oslo, Norway

[5] Norwegian Heart & Lung Patient Org, Oslo, Norway

[6] Norwegian Directorate Hlth, Oslo, Norway

[7] Univ Tromso, Dept Community Med, N-9001 Tromso, Norway

[8] Norwegian Knowledge Ctr Hlth Serv, Oslo, Norway

来源：

BMJ-BRITISH MEDICAL JOURNAL | 2011年 / 343卷

关键词：

EUROPEAN GUIDELINES; CLINICAL-PRACTICE; IMPLEMENTATION; DRUGS; MODEL;

D O I：

10.1136/bmj.d3626

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

[No abstract available]

引用

页数：7

共 19 条

[1] Cardiovascular risk models - Moral implications of models based on absolute risk could be better understood [J].

Bonneux, Luc .

BMJ-BRITISH MEDICAL JOURNAL, 2007, 335 (7611) :107-108

[2] DISCOUNTING THE FUTURE [J].

BROOME, J .

PHILOSOPHY & PUBLIC AFFAIRS, 1994, 23 (02) :128-156

[3]

FRETHEIM A, 2008, 202008 NASJ KUNNSK H

[4] Estimating the high risk group for cardiovascular disease in the Norwegian HUNT 2 population according to the 2003 European guidelines: modelling study [J].

Getz, L ;

Sigurdsson, JA ;

Hetlevik, I ;

Kirkengen, AL ;

Romundstad, S ;

Holmen, J .

BMJ-BRITISH MEDICAL JOURNAL, 2005, 331 (7516) :551-554A

[5] Ethical dilemmas arising from implementation of the European guidelines on cardiovascular disease prevention in clinical practice - A descriptive epidemiological study [J].

Getz, L ;

Kirkengen, AL ;

Hetlevik, I ;

Romundstad, S ;

Sigurdsson, JA .

SCANDINAVIAN JOURNAL OF PRIMARY HEALTH CARE, 2004, 22 (04) :202-208

[6] European guidelines on cardiovascular disease prevention in clinical practice: Full text [J].

Graham, Ian ;

Atar, Dan ;

Borch-Johnsen, Knut ;

Boysen, Gudrun ;

Burell, Gunilla ;

Cifkova, Renata ;

Dallongeville, Jean ;

De Backer, Guy ;

Ebrahim, Shah ;

Gjelsvik, Bjorn ;

Herrmann-Lingen, Christoph ;

Hoes, Arno ;

Humphries, Steve ;

Knapton, Mike ;

Perk, Joep ;

Priori, Silvia G. ;

Pyorala, Kalevi ;

Reiner, Zeljko ;

Ruilope, Luis ;

Sans-Menendez, Susana ;

Reimer, Wilma Scholte Op ;

Weissbergh, Peter ;

Wood, David ;

Yarnell, John ;

Zamorano, Jose Luis .

EUROPEAN JOURNAL OF CARDIOVASCULAR PREVENTION & REHABILITATION, 2007, 14 :S1-S113

[7] GRADE:: what is "quality of evidence" and why is it important to clinicians? [J].

Guyatt, Gordon H. ;

Oxman, Andrew D. ;

Vist, Gunn E. ;

Kunz, Regina ;

Falck-Ytter, Yngve ;

Schunemann, Holger .

BMJ-BRITISH MEDICAL JOURNAL, 2008, 336 (7651) :995-999B

[8] Does implementation of the European guidelines based on the SCORE model double the number of Norwegian adults who need cardiovascular drugs for primary prevention? The Tromso study 2001 [J].

Hartz, I ;

Njolstad, I ;

Eggen, AE .

EUROPEAN HEART JOURNAL, 2005, 26 (24) :2673-2680

[9]

Hetlevik I., 1999, THESIS NORWEGIAN U S

[10]

Jackson R, 2005, LANCET, V365, P434, DOI 10.1016/S0140-6736(05)17833-7

← 1 2 →